Senseonics Amends Loan Agreement with Hercules to Increase Borrowing Capacity
Senseonics Holdings, Inc. has amended its Loan and Security Agreement with Hercules Capital to increase its borrowing capacity from $100 million to $140 million, bolstering its financial resources to fund operations and support its commercial efforts, including the anticipated launch of its Freedom glucose monitoring product in 2028.
GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) — Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to transform lives in the global diabetes community, announced that it has entered into a Second Amendment to the Loan and Security Agreement with Hercules Capital, Inc. (NYSE: HTGC). The Second Amendment increases the maximum borrowing capacity under the existing facility from $100 million to $140 million.